Sort   by:  
 Page size 
UnknownTET2 binds the androgen receptor and loss is associated with prostate cancer.
Not available
S-EPMC5391277 | biostudies-literature
UnknownComprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
Not available
S-EPMC4775252 | biostudies-literature
UnknownWhole-genome analyses resolve early branches in the tree of life of modern birds.
Not available
S-EPMC4405904 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownEmpagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7614055 | biostudies-literature
UnknownSporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4301065 | biostudies-literature
UnknownMacular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC3737287 | biostudies-literature
Sort   by:  
 Page size